Literature DB >> 29416130

Spondyloarthritis: Effects of certolizumab pegol sustained at 4 years.

Sarah Onuora.   

Abstract

Entities:  

Year:  2018        PMID： 29416130     DOI： 10.1038/nrrheum.2018.20

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial.

Authors:  Désirée van der Heijde; Xenofon Baraliakos; Kay-Geert A Hermann; Robert B M Landewé; Pedro M Machado; Walter P Maksymowych; Owen R Davies; Natasha de Peyrecave; Bengt Hoepken; Lars Bauer; Tommi Nurminen; Juergen Braun
Journal:  Ann Rheum Dis       Date:  2018-01-17       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.